跳至主要内容
临床试验/CTRI/2025/06/088484
CTRI/2025/06/088484尚未招募不适用

A CONTROLLED CLINICAL STUDY OF USIRADYA TAILAM UTTARBASTI IN THE MANAGEMENT OF MUTRAGHATA OPEN PARENTHESIS BPH CLOSE PARENTHESIS

S.V. Ayurvedic College and Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年6月25日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To evaluate the clinical efficacy of Usiradya taila Uttarbasti in reducing the size of the prostate and also reducing the post void residual urine in Benign Prostatic

研究概览

简要总结

The Vatashtheela Mutraghata reflects the symptoms of urine retention, incomplete voiding, dribbling, hesitancy, dysuria, straining during urination etc. These are feature of Lower Urinary Tract Symptoms and can be co–related with Benign Prostatic Hyperplasia in modern parlance. Being prostatic hyperplasia is one of the most prevalent obstructive uropathy of advanced age group people above the incidence has been estimated that 5-10% of men at their age of 40 have Prostatic enlargement & 80% by their age of 80 have evidence of BPH. Clinical features of BPH are hesitancy, dysuria, frequency, urgency, haematuria, pain, retention of urine renal failure, prostatism stream of urine, straining during micturition etc. and often features of acute or chronic retention of urine and uraemia also occurs during progression of disease.

Much advancement both technical and surgical nature have come into existence but still satisfactory treatment of the problemis not found in the modern surgery and urology. The methods like TURP (Trans Urethral Resection of Prostate), TUNA (Trans Urethral Needle Ablation), TUMT (Trans Urethral Microwave Thermotherapy), High-intensity focused ultrasound, TUE(Trans Urethral Electro vaporization, water induced thermotherapy and prostatic stent insertion are in practice but still not comprehensive.

In Ayurveda elaborated description regarding the management of Astheela is found across the samhitas and later works of medieval and modern period of Ayurveda. As discussed earlier the main cause for formation of the disease is Vatadosha, which is either in vridhiavastha or in avrutaavastha, Other contributory doshas are kapha and pitta.

The major chikista sutra formulated for these conditions includes the measures of pacifying Vata like Avagahaswedam, Uttaravasti and other procedures causing the Vatanulomanam. There are many drugs and compounds known to have good effect on Prosate and its pathology.

Benign Prostatic Hyperplasia is a condition which left untreated may lead to acute urinary retention, urinary tract infections, renal failure in due course of time. In modern system of medicines, Benign Prostatic Hyperplasia is managed with both conservative and surgical treatment modalities, but they are too expensive. The surgical correction also has potential complications including stricture of urethra, incontinence of urine. In Ayurveda, the management of Benign Prostatic Hyperplasia is done by adopting the principles of mutrakrcchra and mutraghata chikitsa,mutravegadharanajanya vikara cikitsa and granthi cikitsa which include avapidaka snehapana, vasti, ksara prayoga.

Thus the present study is entilted as  A CLINICAL EVALUATION OF USHEERADYA TAILAM UTTARBASTI THE MANAGEMENT OF MUTRAGHATA (BPH)

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant Blinded

入排标准

年龄范围
45.00 Year(s) 至 80.00 Year(s)(—)
性别
Male

入选标准

  • Patient diagnosis confirmed by USG.
  • Patients having the sign and symptoms of mutraghata BPH.

排除标准

  • 1.Age below 45 years.
  • 2.Patients suffering from malignancy, congenital deformities of urogenital tract or any other pelvic pathology.
  • 3.Uncontrolled Hypertension, Diabetic Mellitus.
  • 4.Urogenital tuberculosis.
  • 5.Paralysis.

结局指标

主要结局

To evaluate the clinical efficacy of Usiradya taila Uttarbasti in reducing the size of the prostate and also reducing the post void residual urine in Benign Prostatic

时间窗: DURATION 1 Month | Patient is given Uttarvasti on every alternate day for 1 week for 4 times in a | week in the First sitting. | And given the gap for 2 weeks, and adviced to come for 2 nd sitting of uttar | vasti | Investigation and Assesment is done before treatment and after 2 sittings.

Hyperplasia.

时间窗: DURATION 1 Month | Patient is given Uttarvasti on every alternate day for 1 week for 4 times in a | week in the First sitting. | And given the gap for 2 weeks, and adviced to come for 2 nd sitting of uttar | vasti | Investigation and Assesment is done before treatment and after 2 sittings.

次要结局

  • To evaluate the clinical efficacy of Dhanvatara tailam Uttara basti in reducing the size of the prostate & also reducing the post void residual urine in Benign Prostatic Hyperplasia.(To Compare the efficacies of Usiradya taila Uttarbasti & Dhanvantara tailam Uttar)

研究者

发起方
S.V. Ayurvedic College and Hospital
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验